Impact of Reinfection with SARS-CoV-2 Omicron Variants in Previously Infected Hamsters

• Published in: Journal of virology 2023-01, Vol.97 (1), p.e0136622-e0136622
• Main Authors: Shiwa-Sudo, Nozomi, Sakai, Yusuke, Iwata-Yoshikawa, Naoko, Watanabe, Shinji, Yamada, Souichi, Kuroda, Yudai, Yamamoto, Tsukasa, Shirakura, Masayuki, Fujisaki, Seiichiro, Miyazaki, Kaya, Miura, Hideka, Nagata, Shiho, Fukushi, Shuetsu, Maeda, Ken, Hasegawa, Hideki, Suzuki, Tadaki, Nagata, Noriyo
• Format: Article
• Language: English
• Subjects: Animals; COVID-19; Cricetinae; Host-Microbial Interactions; Mesocricetus; Pathogenesis and Immunity; Reinfection; RNA, Viral; SARS-CoV-2 - genetics
• ISSN: 0022-538X; 1098-5514
• DOI: 10.1128/jvi.01366-22

The diversity of SARS-CoV-2 mutations raises the possibility of reinfection of individuals previously infected with earlier variants, and this risk is further increased by the emergence of the B.1.1.529 Omicron variant. In this study, we used an , hamster infection model to assess the potential for individuals previously infected with SARS-CoV-2 to be reinfected with Omicron variant and we also investigated the pathology associated with such infections. Initially, Syrian hamsters were inoculated with a lineage A, B.1.1.7, B.1.351, B.1.617.2 or a subvariant of Omicron, BA.1 strain and then reinfected with the BA.1 strain 5 weeks later. Subsequently, the impact of reinfection with Omicron subvariants (BA.1 and BA.2) in individuals previously infected with the BA.1 strain was examined. Although viral infection and replication were suppressed in both the upper and lower airways, following reinfection, virus-associated RNA was detected in the airways of most hamsters. Viral replication was more strongly suppressed in the lower respiratory tract than in the upper respiratory tract. Consistent amino acid substitutions were observed in the upper respiratory tract of infected hamsters after primary infection with variant BA.1, whereas diverse mutations appeared in hamsters reinfected with the same variant. Histopathology showed no acute pneumonia or disease enhancement in any of the reinfection groups and, in addition, the expression of inflammatory cytokines and chemokines in the airways of reinfected animals was only mildly elevated. These findings are important for understanding the risk of reinfection with new variants of SARS-CoV-2. The emergence of SARS-CoV-2 variants and the widespread use of COVID-19 vaccines has resulted in individual differences in immune status against SARS-CoV-2. A decay in immunity over time and the emergence of variants that partially evade the immune response can also lead to reinfection. In this study, we demonstrated that, in hamsters, immunity acquired following primary infection with previous SARS-CoV-2 variants was effective in preventing the onset of pneumonia after reinfection with the Omicron variant. However, viral infection and multiplication in the upper respiratory tract were still observed after reinfection. We also showed that more diverse nonsynonymous mutations appeared in the upper respiratory tract of reinfected hamsters that had acquired immunity from primary infection. This hamster model reveals the within-host ev